Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NASDAQ:ULBI

Ultralife Q3 2026 Earnings Date & Estimates

Ultralife logo
$6.07 0.00 (0.00%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$6.08 +0.00 (+0.08%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ultralife is estimated to report Q3 2026 earnings on Monday, October 26, 2026, before market opens.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens

What Analysts Expect from Ultralife in Q3 2026

Ultralife is expected to post earnings of $0.23 per share on revenue of $56.00 million. In the same quarter a year earlier Ultralife reported -$0.07 per share on revenue of $43.37 million. Ultralife last reported on August 7, 2026, posting $0.19 per share and matching the $0.19 consensus estimate. Ultralife has beaten the consensus EPS estimate in 1 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.23
Expected Revenue
$56.00 million
Prior-Year EPS
-$0.07
Prior-Year Revenue
$43.37 million
Expected Revenue Growth
+29.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.19 (Met Expectations)
Last Quarter Revenue
$47.94 million
EPS Beat Rate
1 of last 8 quarters

Ultralife Q3 2026 Earnings FAQ

Ultralife (NASDAQ:ULBI) is estimated to report Q3 2026 earnings on Monday, October 26, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Ultralife's Q3 2026 earnings conference call is scheduled for Tuesday, November 17, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Ultralife to post earnings of $0.23 per share for Q3 2026.

The consensus revenue estimate for Ultralife is $56.00 million for Q3 2026.

Ultralife Earnings Headlines

Ultralife (ULBI) Expected to Announce Quarterly Earnings on Thursday
Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel
See More Ultralife Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ultralife? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ultralife and other key companies, straight to your email.

About Ultralife

Ultralife (NASDAQ:ULBI) is a New York-based manufacturer of power and communications products serving government, defense, aerospace, industrial, medical and other specialized markets. The company develops and produces batteries, battery packs, chargers and related power-management products designed for portable and mission-critical equipment.

Ultralife’s product portfolio includes lithium primary and rechargeable batteries, custom battery assemblies, military battery systems, charging equipment and accessories. Its communications business provides products such as radio and communications accessories, amplifiers, adapters and related equipment used in field and tactical applications.

Founded in 1990, Ultralife sells its products through direct sales, distributors and original equipment manufacturers in the United States and international markets. The company is led by Michael D. Popielec, who serves as president and chief executive officer.

View Ultralife Profile